Seroquel is a prescription medication marketed in Hong Kong as a pill formulation containing the active ingredient quetiapine. It belongs to the therapeutic class of mental health agents, specifically the atypical antipsychotic group. The drug is available in the following strengths: 25 mg, 50 mg, 100 mg, 200 mg, and 300 mg. As a regulated prescription product, it may only be dispensed by a licensed pharmacist upon presentation of a valid prescription from a qualified healthcare professional. In Hong Kong, the Department of Health oversees its approval and post-marketing surveillance.
Quetiapine exerts its therapeutic effect by modulating several neurotransmitter systems in the brain:
The medication is well absorbed after oral ingestion, with peak plasma concentrations typically reached within 1-2 hours. Its elimination half-life ranges from 6 to 7 hours, allowing once-daily or twice-daily dosing depending on the clinical indication. Metabolism occurs mainly via the cytochrome P450 3A4 (CYP3A4) pathway, and metabolites are excreted primarily in the urine.
Seroquel is approved by the Hong Kong Department of Health for the following indications:
These indications are based on extensive clinical trials demonstrating efficacy in reducing psychotic symptoms, stabilising mood swings, and improving overall functional outcomes.
Some clinicians prescribe quetiapine for conditions that lie outside its official labeling. Research evidence varies:
Disclaimer: Off-label use of Seroquel is not approved by the Hong Kong regulatory authorities. Such use requires careful medical supervision, individualized risk assessment, and informed consent.
Special populations, including the elderly and those with renal dysfunction, should be evaluated individually, and dosing may need to be reduced.
Standard dosing varies by condition. Typical regimens start at the lowest available strength and are titrated upward based on response and tolerability.
Schizophrenia: Initiate with 25 mg twice daily; increase by 25-50 mg increments every 2-3 days to a target of 300-400 mg daily (divided doses).
Bipolar mania: Begin with 50 mg twice daily; titrate to 400-800 mg daily as needed.
Bipolar depression / adjunctive depression: Start at 50 mg once daily (evening) and may increase to 300 mg daily.
Administration: Swallow tablets whole with a glass of water. Do not crush or chew, unless instructed by a pharmacist.
Missed dose: Take the missed tablet as soon as remembered unless the next scheduled dose is imminent; do not double the dose.
Overdose: Signs include severe sedation, tachycardia, hypotension, and possible seizures. Seek emergency medical care; supportive measures and activated charcoal may be employed.
Discontinuation: Abrupt cessation can lead to rebound insomnia, agitation, or relapse of psychosis. Tapering under medical guidance is recommended, especially after long-term use.
Note: Exact dosing must be individualized; the above schedules are general guidance based on typical clinical practice and the listed tablet strengths.
This article provides educational information about Seroquel and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
Low-dose quetiapine (25-50 mg) is sometimes prescribed for its sedating properties, but it is not approved specifically for insomnia. The sedative effect may lead to weight gain and metabolic changes, so clinicians usually reserve this use for patients who also require antipsychotic treatment.
If you remember the missed dose within a few hours, you may take it. If the next scheduled dose is soon, skip the missed tablet and continue with your regular dosing schedule. Never double a dose without medical advice.
Some patients report blurred vision or difficulty focusing, especially when starting therapy or after dose increases. These effects are usually transient but should be reported if they persist or affect daily activities.
Both are atypical antipsychotics, but quetiapine has a stronger antihistamine effect, leading to more pronounced sedation. Risperidone tends to have a higher propensity for prolactin elevation. Choice of agent depends on the individual’s symptom profile and side-effect tolerance.
Quetiapine is categorized as Pregnancy Category C in Hong Kong, meaning animal studies have shown risk and there are no well-controlled human studies. It should be prescribed only when the potential benefit justifies the possible risk to the fetus.
Alcohol can intensify central nervous system depression, increasing drowsiness, dizziness, and the risk of falls. It is advisable to limit or avoid alcohol while on therapy.
Quetiapine can impair glucose tolerance. Baseline fasting glucose or HbA1c should be obtained, with periodic reassessment (e.g., every 3-6 months) in patients at risk for diabetes.
Both quetiapine and many antihistamines have sedating properties. Combined use may increase drowsiness and impair cognition, so caution is recommended.
Improvement in psychotic symptoms often begins within 1-2 weeks, while mood stabilization in bipolar disorder may require 2-4 weeks of consistent dosing. Full therapeutic benefit may take up to several weeks.
Do not flush them down the toilet or discard them in household trash. Participate in a pharmacy-based medication take-back program or follow local hazardous-waste disposal instructions to protect the environment and prevent accidental ingestion.
